Wolfgang Miesbach: A New Genetic Perspective on the Worldwide Burden of von Willebrand Disease
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn about a recent article by Omid Seidizadeh et al, published in Nature Scientific Reports, adding:
”How common is von Willebrand disease?
Far more prevalent than registries indicate.
A new Nature study uses gnomAD v4.1 (807,000+ sequenced individuals) and Hardy–Weinberg genetic modeling on 321 pathogenic/likely pathogenic VWF variants to refine the global genetic prevalence of von Willebrand disease (VWD).
By filtering 10,397 VWF variants down to this high‑confidence pathogenic set and applying Hardy–Weinberg models, the authors report a strikingly high global prevalence:
- approximately 11 per 1,000 for type 1 (≈1.1% of the population)
- 1.3–1.7 per 1,000 for dominant type 2 variants (2A, 2B, 2M)
- Tens per million for recessive forms (≈34 per million for 2N and ≈1–2 per million for type 3)
- Altogether, this translates into tens of millions of affected individuals worldwide.
The study further maps pathogenic variant clustering across functional VWF domains and highlights ancestry‑specific distributions of key alleles, underscoring both shared VWF biology and population‑specific risk patterns.
For clinical and research practice, these data provide a valuable reference for variant interpretation, support more realistic registry and screening strategies, and reinforce that VWD—particularly mild and qualitative forms—remains substantially underdiagnosed and undertreated.
Congratulations to Omid Seidizadeh, Andrea Cairo, Camilla Oriani and Flora Peyvandi.”
Title: Updated global prevalence and ethnic diversity of von Willebrand disease based on population genetics analysis
Authors: Omid Seidizadeh, Andrea Cairo, Camilla Oriani, Flora Peyvandi

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin
-
Aug 10, 2026, 15:47Edward Lee Carter: 61% of Patients on Reduced-Dose Apixaban Did Not Meet Label Criteria
-
Aug 10, 2026, 15:45Vrushali Lad: What Living With DVT Taught Me About Lifestyle and Movement